Amedeo Smart

Free Medical Literature Service

 

Amedeo

Multiple Sclerosis
  Free Subscription

Articles published in
Proc Natl Acad Sci U S A
    May 2023
  1. CAVERZASI E, Papinutto N, Cordano C, Kirkish G, et al
    MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial.
    Proc Natl Acad Sci U S A. 2023;120:e2217635120.
    >> Share

    April 2023
  2. KAPATE N, Dunne M, Kumbhojkar N, Prakash S, et al
    A backpack-based myeloid cell therapy for multiple sclerosis.
    Proc Natl Acad Sci U S A. 2023;120:e2221535120.
    >> Share

  3. GHAREGHANI M, Zibara K, Rivest S
    Melatonin and vitamin D, two sides of the same coin, better to land on its edge to improve multiple sclerosis.
    Proc Natl Acad Sci U S A. 2023;120:e2219334120.
    >> Share

    March 2023
  4. MADER S, Ho S, Wong HK, Baier S, et al
    Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein.
    Proc Natl Acad Sci U S A. 2023;120:e2300648120.
    >> Share

    February 2023
  5. HEMING M, Wiendl H
    Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy.
    Proc Natl Acad Sci U S A. 2023;120:e2221544120.
    >> Share

    January 2023
  6. SHINODA K, Li R, Rezk A, Mexhitaj I, et al
    Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
    Proc Natl Acad Sci U S A. 2023;120:e2207291120.
    >> Share

  7. JANOSCHKA C, Lindner M, Koppers N, Starost L, et al
    Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.
    Proc Natl Acad Sci U S A. 2023;120:e2209944120.
    >> Share

    October 2022
  8. KWIATKOWSKI AJ, Helm EY, Stewart JM, Drashansky TT, et al
    Treatment with an antigen-specific dual microparticle system reverses advanced multiple sclerosis in mice.
    Proc Natl Acad Sci U S A. 2022;119:e2205417119.
    >> Share

  9. BEHRANGI N, Heinig L, Frintrop L, Santrau E, et al
    Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.
    Proc Natl Acad Sci U S A. 2022;119:e2204509119.
    >> Share

    August 2022
  10. MEYER T, Shimon D, Youssef S, Yankovitz G, et al
    NAD(+) metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity.
    Proc Natl Acad Sci U S A. 2022;119:e2211310119.
    >> Share

  11. DIEBOLD M, Galli E, Kopf A, Sanderson NSR, et al
    High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2022;119:e2205042119.
    >> Share

    June 2022
  12. ZAHOOR I, Suhail H, Datta I, Ahmed ME, et al
    Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.
    Proc Natl Acad Sci U S A. 2022;119:e2123265119.
    >> Share

  13. KIM S, Lu HC, Steelman AJ, Li J, et al
    Myeloid caspase-8 restricts RIPK3-dependent proinflammatory IL-1beta production and CD4 T cell activation in autoimmune demyelination.
    Proc Natl Acad Sci U S A. 2022;119:e2117636119.
    >> Share

    April 2022
  14. YU L, He L, Gan B, Ti R, et al
    Structural insights into sphingosine-1-phosphate receptor activation.
    Proc Natl Acad Sci U S A. 2022;119:e2117716119.
    >> Share

  15. HWANG D, Seyedsadr MS, Ishikawa LLW, Boehm A, et al
    CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.
    Proc Natl Acad Sci U S A. 2022;119:e2111804119.
    >> Share

    March 2022
  16. SARRAZIN N, Chavret-Reculon E, Bachelin C, Felfli M, et al
    Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration, retinal damages, and visual dysfunction.
    Proc Natl Acad Sci U S A. 2022;119:e2115973119.
    >> Share

  17. CHUNDER R, Weier A, Maurer H, Luber N, et al
    Antibody cross-reactivity between casein and myelin-associated glycoprotein results in central nervous system demyelination.
    Proc Natl Acad Sci U S A. 2022;119:e2117034119.
    >> Share

    February 2022
  18. GUO X, Kimura A, Namekata K, Harada C, et al
    ASK1 signaling regulates phase-specific glial interactions during neuroinflammation.
    Proc Natl Acad Sci U S A. 2022;119.
    >> Share

    December 2021
  19. MA Q, Caillier SJ, Muzic S, Wilson MR, et al
    Specific hypomethylation programs underpin B cell activation in early multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  20. CHANDRAN V, Bermudez ML, Koka M, Chandran B, et al
    Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    November 2021
  21. VARATHARAJ A, Carare RO, Weller RO, Gawne-Cain M, et al
    Gadolinium enhancement of cranial nerves: Implications for interstitial fluid drainage from brainstem into cranial nerves in humans.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    October 2021
  22. MANOUCHEHRI N, Stuve O
    Choroid plexus volumetrics and brain inflammation in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    September 2021
  23. FLEISCHER V, Gonzalez-Escamilla G, Ciolac D, Albrecht P, et al
    Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  24. HARTLEHNERT M, Borsch AL, Li X, Burmeister M, et al
    Bcl6 controls meningeal Th17-B cell interaction in murine neuroinflammation.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    August 2021
  25. LONGBRAKE EE, Hafler DA
    (23)Na imaging: Worth its salt for understanding multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  26. JING X, Yao Y, Wu D, Hong H, et al
    IFP35 family proteins promote neuroinflammation and multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    July 2021

  27. Correction for Ostkamp et al., Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  28. HUHN K, Linz P, Pemsel F, Michalke B, et al
    Skin sodium is increased in male patients with multiple sclerosis and related animal models.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  29. COLOMBO E, Triolo D, Bassani C, Bedogni F, et al
    Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    June 2021
  30. PATERGNANI S, Bonora M, Ingusci S, Previati M, et al
    Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    May 2021
  31. BARNES SE, Han MH
    CD317 puts the brakes on dendritic cell trafficking to the CNS.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    April 2021
  32. ZHELEZNYAKOVA GY, Piket E, Needhamsen M, Hagemann-Jensen M, et al
    Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    March 2021
  33. RONIN E, Pouchy C, Khosravi M, Hilaire M, et al
    Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing Treg cells.
    Proc Natl Acad Sci U S A. 2021;118:e2014043118.
    >> Share

  34. RAVENEY BJE, Sato W, Takewaki D, Zhang C, et al
    Involvement of cytotoxic Eomes-expressing CD4(+) T cells in secondary progressive multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    February 2021
  35. KHAW YM, Tierney A, Cunningham C, Soto-Diaz K, et al
    Astrocytes lure CXCR2-expressing CD4(+) T cells to gray matter via TAK1-mediated chemokine production in a mouse model of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  36. TEO W, Caprariello AV, Morgan ML, Luchicchi A, et al
    Nile Red fluorescence spectroscopy reports early physicochemical changes in myelin with high sensitivity.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    January 2021
  37. OSTKAMP P, Salmen A, Pignolet B, Gorlich D, et al
    Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

    December 2020
  38. KENISON JE, Jhaveri A, Li Z, Khadse N, et al
    Tolerogenic nanoparticles suppress central nervous system inflammation.
    Proc Natl Acad Sci U S A. 2020;117:32017-32028.
    >> Share

    October 2020
  39. MONTGOMERY TL, Kunstner A, Kennedy JJ, Fang Q, et al
    Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
    Proc Natl Acad Sci U S A. 2020 Oct 19. pii: 2002817117.
    >> Share

    September 2020
  40. NISSIMOV N, Hajiyeva Z, Torke S, Grondey K, et al
    B cells reappear less mature and more activated after their anti-CD20-mediated depletion in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2020 Sep 30. pii: 2012249117.
    >> Share

  41. DIDONNA A, Canto Puig E, Ma Q, Matsunaga A, et al
    Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis.
    Proc Natl Acad Sci U S A. 2020 Sep 2. pii: 2003798117.
    >> Share

  42. MONDAL S, Kundu M, Jana M, Roy A, et al
    IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rbeta1 internalization and suppress EAE.
    Proc Natl Acad Sci U S A. 2020;117:21557-21567.
    >> Share

    August 2020
  43. O'CONNELL GC, Alder ML, Smothers CG, Chang JHC, et al
    Large-scale informatic analysis to algorithmically identify blood biomarkers of neurological damage.
    Proc Natl Acad Sci U S A. 2020;117:20764-20775.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016